Latin America Blood Glucose Monitor Market worth $1.79 billion in 2030
The report "Latin America Blood Glucose Monitor Market by Product (Blood Glucose Monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site (Fingertip, Upper Arm), End User (Self/Homecare) - Forecast to 2030" is projected to grow from USD 1.14 billion in 2025 and to reach USD 1.79 billion in 2030, at a Compound Annual Growth Rate (CAGR) of 9.5% during the forecast period.
Browse 150 market data Tables and 40 Figures spread through 250 Pages and in-depth TOC on "Latin America Blood Glucose Monitor Market by Product (Blood Glucose Monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site (Fingertip, Upper Arm), End User (Self/Homecare) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/latin-america-blood-glucose-monitor-market-5675103.html
Industry development in the Latin America blood glucose monitor market closely aligns with national healthcare priorities focused on improving diabetes detection, long-term disease management, and cost-effective care. Demand is driven by the growing diabetic population, increased focus on early diagnosis and regular monitoring, and wider adoption of home- and outpatient-based care. The aging population in Brazil, Mexico, and Argentina, combined with rising lifestyle-related diabetes prevalence, further underscores the need for frequent and reliable glucose monitoring. However, market adoption varies across the region, as differences in reimbursement coverage, pricing regulations, and public healthcare procurement frameworks can limit the uptake of newer and higher-cost blood glucose monitoring technologies.
“Self-monitoring blood glucose systems segment accounted for the largest market share in 2024”
Based on product type, the Latin America blood glucose monitor market is categorized into self-monitoring blood glucose (SMBG) systems, continuous glucose monitoring (CGM) systems, professional point-of-care systems, and non-invasive systems. In 2024, the SMBG systems held the largest market share in 2024, mainly due to their low cost, easy availability, and high adoption rate among the large number of diabetics in Brazil, Mexico, and Argentina. SMBG systems are widely used by patients with Type 2 diabetes, especially in the early stages of the condition or when managed through lifestyle modifications and oral antidiabetics. The market dominance of SMBG systems in Latin America is backed by the little-to-no reimbursement of CGM systems, high out-of-pocket healthcare spending, and robust distribution channels through retail pharmacies, hospital pharmacies, and e-commerce platforms. Furthermore, the competitive pricing of test strips, local distribution of meters, and constant advancements in the accuracy, speed, and mobile connectivity of SMBG systems have maintained their relevance in glucose monitoring in Latin America.
“Diabetes management segment is expected to grow at the highest CAGR during the forecast period”
By application, the Latin America blood glucose monitor market is segmented into diabetes management, health & wellness monitoring, and other applications, with diabetes management expected to register the highest growth rate during the forecast period. Growth in this segment is primarily driven by the rising number of diabetes patients in Brazil, Mexico, and Argentina, as well as the increasing focus on early diagnosis and long-term glycemic control in public and private healthcare systems. Several Latin American countries are strengthening national diabetes programs and clinical guidelines, encouraging routine blood glucose monitoring as a key part of standard diabetes care. The gradual adoption of continuous glucose monitoring (CGM), particularly among insulin-dependent and high-risk patients, is also supporting growth. However, overall penetration remains limited due to low reimbursement coverage and high out-of-pocket costs. Additionally, physician awareness, patient education initiatives, and the expanding availability of self-monitoring devices through hospital pharmacies, retail pharmacies, and online platforms are collectively driving the adoption of blood glucose monitoring solutions for diabetes management across the region.
“Mexico is likely to register a significant CAGR between 2025 and 2030”
Mexico is expected to record the second-highest CAGR in the Latin America blood glucose monitor market during the forecast period, supported by the rapidly rising diabetes burden and high prevalence of lifestyle-related risk factors. According to the IDF Atlas 2025, approximately 13.6 million people in the country were living with diabetes in 2024, and this figure is projected to reach 19.9 million by 2050, reflecting a substantial expansion of the target patient pool. The growing incidence of obesity and sedentary lifestyles, particularly in urban regions, is increasing the need for frequent blood glucose testing among both diagnosed and undiagnosed populations. In addition, the strong penetration of retail pharmacies and private diagnostic laboratories is facilitating wider availability and routine use of blood glucose monitoring devices, reinforcing market growth in the country.
Key Players
Prominent players in the Latin America blood glucose monitor market include Abbott Laboratories (US), Dexcom, Inc. (US), Medtronic (Ireland), Sinocare (China), B.Braun SE (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Ascensia Diabetes Care Holdings AG (Switzerland), Senseonics (US), Nipro (Japan), Arkray (Japan), Medical Technology and Devices S.p.A. (Italy), Terumo Corporation (Japan), i-SENS, Inc. (South Korea), LifeScan IP Holdings, LLC (US), and SD Biosensor, INC (South Korea).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Latin America Blood Glucose Monitor Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
